Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
about
Treating BCG-induced disease in childrenTreatments for BCG-induced disease in childrenThe benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model.Novel multiplex PCR using dual-priming oligonucleotides for detection and discrimination of the Mycobacterium tuberculosis complex and M. bovis BCG.Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts.Bacillus Calmette-Guérin-related cold thigh abscess as an unusual cause of thigh swelling in infants following BCG vaccine administration: a case series.Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions.Pharmacovigilance in children: detecting adverse drug reactions in routine electronic healthcare records. A systematic review.Case 1: Axillary mass in a First Nations infant.Recommendations for pediatric tuberculosis vaccination in ItalyCLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN.Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.Nonresponding osteomyelitis in a two-year-old boyBCGitis: A rare complication after intravesical BCG therapy.Severe combined immunodeficiency (SCID) in Canadian children: a national surveillance study.The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseases.Severe cutaneous bacillus Calmette-Guérin infection in immunocompromised children: the relevance of skin biopsy
P2860
Q24201807-A1BBE493-FD82-49FE-B967-D772613967A9Q24239915-55A66C59-63B5-4A18-A782-D6C367E428C7Q33235419-BDDBAC85-C989-46CB-A29E-8045DC8AE06FQ34433092-3E435FEA-B90C-4ED8-A5B3-125383F6765EQ35225633-A3DE45AD-9161-451D-A439-9D586642BF43Q35290153-06A48A1A-A81E-42DF-B9AF-ACB37F6B3285Q36092315-F47CB21C-66A8-4422-B5F5-1DAE362C49A9Q36125536-D6FB6C26-491C-4FC3-A9A8-74E5996748D5Q36251841-DE6F59EC-1D46-4371-B1A7-755F5A4F9096Q37135291-D6EF7B5B-30A7-438B-BE63-2DCD41F6ACABQ37395397-832AB2C9-D090-4708-96D1-B6EF6952D765Q38283208-D8FDFB92-CC5A-4853-A2F0-CD9233C1B6EFQ41280332-61BB663D-5CEC-4C35-A241-14B03D5CD57AQ43185928-A058423C-2730-4D35-84D7-7EDFFE55C7D0Q45128775-0A629F1D-8182-4956-B0AE-1C98D584793AQ55005104-33D8E353-3845-4FC3-8243-9C4A1C134494Q57014577-B2FBD1EC-67DE-459C-AB0E-2059A5371C5A
P2860
Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
@ast
Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
@en
type
label
Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
@ast
Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
@en
prefLabel
Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
@ast
Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
@en
P2093
P1476
Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
@en
P2093
Arlene King
Barbara J Law
C Edward Ellis
Meenakshi Dawar
Michael Clark
Nooshin Ahmadipour
Shelley L Deeks
Wikke Walop
P304
P356
10.1097/01.INF.0000164769.22033.2C
P577
2005-06-01T00:00:00Z